Parvinder Thiara - 22 Jun 2023 Form 3 Insider Report for Zura Bio Ltd (ZURA)

Role: Director, 10%+ Owner
Signature: By: /s/ Parvinder Thiara
Issuer symbol: ZURA
Transactions as of: 22 Jun 2023
Net transactions value: $0
Form type: 3
Filing time: 02 Oct 2023, 21:54:33 UTC
Next filing: 23 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ZURA	Class A Ordinary Shares						6,801,633	22 Jun 2023	By Funds	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ZURA	Warrants							22 Jun 2023	Class A Ordinary Shares	1,194,000	$11.50	By Funds	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Thiara was appointed as a director of Zura Bio Limited effective June 22, 2023.
F2	Athanor Master Fund, LP (the "Master Fund") and Athanor International Master Fund, LP (the "International Master Fund", and together with the Master Fund, the "Funds") are the direct holders of the securities reported herein. Athanor Capital Partners, LP ("Master GP") is the general partner of the Master Fund. Athanor Capital Partners GP, LLC is the general partner of Master GP. Athanor International Fund GP, LP ("International Master GP") is the general partner of the International Master Fund. Athanor International Fund Ultimate GP, LLC is the general partner of International Master GP. Athanor Capital, LP ("Athanor Capital") is the investment adviser to the Funds. Athanor Capital GP, LLC is the general partner of Athanor Capital. Parvinder Thiara is the managing member of Athanor Capital Partners GP, LLC, Athanor International Fund Ultimate GP, LLC and Athanor Capital GP, LLC.
F3	By virtue of the foregoing relationships, Mr. Thiara and each of the entities named in this footnote may be deemed to beneficially own the securities held by the Funds, however each of them disclaims beneficial ownership of such securities, except to the extent of his or its pecuniary interest therein.